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Abstract: Nasopharyngeal carcinoma (NPC) is one of the most common malignancies in the head and neck region, espe-
cially among those of Chinese origin. NPC has multifactorial aetiologies including genetic susceptibility, consumption of 
food with high salt content, and the Epstein–Barr virus. The primary tumour usually arises from the lateral walls of the 
nasopharynx and is characterized by a rich sub-mucosal lymphatic structure, often leading to cervical lymph node metas-
tasis. Distant metastasis has been recognized to be a major cause of treatment failure in patients with nasopharyngeal car-
cinoma. Bone, liver and lung are the most frequent sites of NPC metastases.  
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INTRODUCTION 
We report an unusual case of NPC that was metastatic to 
the mandible. Others have reported similar unusual presenta-
tions with symptoms that have developed in the maxillofa-
cial region. Recently, Khan et al. [1] reported a patient that 
presented with facial pain of three months duration and lim-
ited mouth opening. MRI and a CT scan revealed a large 
NPC in the nasopharyngeal space. NPC metastasis to the 
parotid gland is extremely rare, but may present as a parotid 
swelling [2].  
It is generally a rare malignancy in developed countries, 
but has a higher incidence in Southern China and Southeast 
Asia. Its incidence in different countries is related to Epstein-
Barr infection rates, with additional smaller environmental 
effects such as smoking and genetic susceptibility playing a 
role [3]. Failure of treatment for NPC often occurs because 
of distant metastases, which is therefore an important factor 
determining survival. Metastasis, in the absence of local re-




A 79 year-old male was referred to our hospital with pus 
discharging for one month from an unhealed intraoral wound 
in the mandibular symphysis area. The panoramic radiograph 
showed that there was a 4 x 3 cm size radiolucent lesion over 
the mandibular symphysis with an irregular border (Fig. 1).  
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Fig. (1). A large radiolucent lesion (between arrows) and a retained 
tooth in the anterior area of mandible at the patient’s first visit to 
our hospital. 
 
There was no palpable lymphadenopathy over the bilateral 
neck area during the physical examination. The patient had a 
history of NPC one year previously, and had received a 
complete radiation therapy course (total dose of 6500 Gy), 
without chemotherapy. A tentative diagnosis of osteomye-
litis of the mandible was made. In order to eliminate the pos-
sibility of NPC metastasis, a chest radiograph, conventional 
bone scanning and liver scanning were arranged. The results 
were negative. CT scanning did not reveal any cervical 
lymph node involvement in the neck area. Under general 
anaesthesia, tooth extraction, sequestrectomy and marginal 
bone resection were performed with a 2 mm safe zone (Fig. 
2). The tissue specimen was whitish in colour and soft with a 
granular texture. The wound was marsupialized and an iodo-
form gauze dressing was placed for 2 weeks. The histopa-
thology report showed an undifferentiated carcinoma with 
frequent mitoses. In-situ hybridization revealed that the 196    The Open Dentistry Journal, 2010, Volume 4  Huang et al. 
specimen contained Epstein-Barr virus RNA. The ENT de-
partment performed a nasopharyngeal examination for the 
possibility of recurrent NPC and the result was negative. The 
case was classified as Ho’s stage II, T1N1M1. 
A CT scan was taken one month after the operation. The 
mandible had healed in the upper border region, but no heal-
ing was evident over the lower margin after surgery (Fig. 3). 
The patient was referred for radiotherapy. After the supple-
mental dose of 50 Gy, further lesion expansion was stopped 
and early bone formation in the inferior lingual aspect of the 
lesion was noted in the following CT scan (Fig. 4). The re-
maining apparent discontinuity of the bone in the grafted 
area most probably represents incomplete healing. 6 months 
after the major surgery, the patient complained of chest pain, 
and received a further chest CT scan. A lung metastasis was 
diagnosed. The patient was then referred to receive salvage 
chemotherapy with 5-flurouracial and cisplatin.  
DISCUSSION 
NPC is considered as surgically unresectable because of 
its anatomical localization. It is primarily treated by radio-
therapy. Distant metastasis has been found to be the major 
cause of mortality with NPC. 5% of patients already have 
distant metastases at presentation and up to 30% are found to 
have distant metastases after primary definitive radiotherapy. 
60–80% of patients have metastatic lymphadenopathy.  
In our patient the radiological examination with whole 
body bone scan, chest radiography and liver scan failed to 
detect the distant metastasis early. In treatment choices, NPC 







































Fig. (4). CT scan 5 months post-operation after salvage radiotherapy showing increased bone formation and a decrease in the residual lesion. 
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therapy results in an overall 5-year survival rate of over 80% 
for Ho’s Stage I and over 70% for Ho’s Stage II disease [5-
10] Chemotherapy is effective in locoregionally recurrent or 
metastatic NPC disease. Distant metastasis is frequent in 
bone, but facial bone involvement has been rarely reported.  
Could the surgical intervention of the oral lesion have 
contributed to the dissemination of the cancer to the lungs? 
The surgical intervention to the jaw was not likely to have 
caused the lung metastasis. A throat pack was used and care 
was taken to avoid aspiration of tumour cells. It is most 
likely that the lung metastasis was a late clinical manifesta-
tion of blood borne dissemination occurring earlier in the 
course of the disease. The muco-ciliary barrier is effective 
and malignant cells need to establish a blood supply to sur-
vive. The patient eventually developed a solitary pulmonary 
metastasis. Options for management in this situation include 
local surgical removal and salvage chemotherapy. The evi-
dence base for surgical removal of metastasis is weak, and is 
most useful for cancers with a prolonged clinical course and 
without wide dissemination. It is widely accepted that naso-
pharyngeal carcinoma disseminates early and the evidence 
available indicates that salvage is best attempted using plati-
num based chemotherapy. 
The mandible may also be affected by osteoradionecro-
sis, which is a rare complication of radiotherapy treatment of 
head and neck tumours. The features of soft tissue thickening 
and cortical bone destruction may lead to an erroneous diag-
nosis of tumour recurrence [11]. The risk of osteoradione-
crosis is greatest with high doses of radiation in patients with 
poor oral hygiene. The buccal cortex in the molar and pre-
molar regions are most commonly affected, while the sym-
physis and angle of the mandible are protected because of 
the blood supply derived from their associated muscle inser-
tions. The trismus, dryness of the oral mucosa and fibrosis of 
sulcular tissues that may follow radiotherapy, can complicate 
examination of the patient’s mouth and any restorative 
treatment [12,13].
 
NPC is primarily treated by radiotherapy, and post-
irradiation osteosarcoma (PIOS) arises as a late complication 
in about 0.04% of people treated. PIOS in NPC is a highly 
malignant disease, which occurs after a prolonged latency 
period following radiotherapy. Wei-wei, et al. [14] found 
that this latency period was about 13 years on average after 
irradiation in their group of patients. The prognosis of radia-
tion-induced sarcoma is worse than that of the primary dis-
ease [15].
 In a group of 12 patients with PIOS following ir-
radiation for NPC, survival ranged from 7 to 41 months, with 
a mean of 18 months [16].
 
The patient’s initial presentation of NPC that was metas-
tatic to the mandible is unusual, with pus discharging for a 
month from an unhealed intraoral wound. In a retrospective 
analysis of 4768 patients with primary NPC, Lee, et al. [17] 
found that the most common presenting complaint was a 
painless enlargement of the upper cervical lymph nodes, 
nasal symptoms (such as discharge, bleeding or obstruction), 
otological problems, headache or cranial nerve dysfunction. 
The importance of early detection is emphasized.  
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